News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celgene (CELG) Gets FDA OK to Expand Use of Lymphoma Drug



6/17/2011 7:52:40 AM

Celgene Corp said it received expedited U.S. regulatory approval to expand the use of its Istodax drug in the treatment of cancers. The biotechnology company said the U.S. Food and Drug Administration granted an accelerated approval for its application to use Istodax to treat peripheral T-cell lymphoma in patients who have received at least one prior therapy. Istodax is already approved in the United States for treating cutaneous T-cell lymphoma in patients who have received at least one prior systemic therapy.

Read at Reuters


comments powered by Disqus
Reuters
   
Lymphoma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES